[144] Lumentum Holdings Inc. SEC Filing
Rhea-AI Filing Summary
Lumentum Holdings Inc. (LITE) Rule 144 notice: An insider has filed a proposed sale of 2,526 common shares through Morgan Stanley Smith Barney LLC on Nasdaq with an aggregate market value of $314,209.14, with an approximate sale date of 08/26/2025. The shares were acquired as performance shares from the issuer on 08/07/2025 and payment/vesting is recorded on that same date. The filer also reported two recent sales in the last three months: 2,222 common shares sold on 08/18/2025 for $258,751.90 and 2,222 common shares sold on 06/04/2025 for $185,714.76. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 disclosure of a small-volume insider sale of recently acquired performance shares; informational for compliance and liquidity tracking.
The filing documents a proposed sale of 2,526 shares with an aggregate market value of $314,209.14 and notes recent disposals of 2,222 shares on 08/18/2025 and 06/04/2025. From an investor-analytic perspective, the disclosure is primarily compliance-driven: it confirms transfer/vesting of performance shares on 08/07/2025 and identifies the brokerage channel for execution. The sizes reported here are modest relative to typical public float for an established Nasdaq issuer, and the filing contains no new operational or financial information about the company itself. Impact on valuation or market dynamics is likely immaterial based solely on the data provided.
TL;DR: Properly filed Rule 144 notice showing insider compliance; no governance red flags visible in the notice itself.
The form identifies the nature of acquisition as performance shares and affirms the seller's representation regarding undisclosed material information. It records the broker (Morgan Stanley Smith Barney LLC) and an intended sale date, which aligns with standard disclosure practices for timely insider dispositions. No indications of trading plan adoption dates or 10b5-1 reliance are provided; the form does not assert a trading plan. From a governance standpoint, the filing meets required transparency standards but supplies no context on motive, timing policy adherence, or any insider trading program details.